We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
+6.96%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$56.9B
AUM Growth
+$2.14B
Cap. Flow
-$875M
Cap. Flow %
-1.54%
Top 10 Hldgs %
31.9%
Holding
1,730
New
18
Increased
385
Reduced
488
Closed
24

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$98.8M
2
EL icon
Estee Lauder
EL
+$92.2M
3
NVDA icon
NVIDIA
NVDA
+$83M
4
AMAT icon
Applied Materials
AMAT
+$63.2M
5
AVGO icon
Broadcom
AVGO
+$58.1M

Sector Composition

Rank Sector Weight
1 Technology 30.11%
2 Healthcare 14.35%
3 Financials 12.69%
4 Consumer Discretionary 9.69%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SONO icon
1601
Sonos
SONO
$1.9B
$512K ﹤0.01%
41,697
CERT icon
1602
Certara
CERT
$1.22B
$509K ﹤0.01%
43,477
THFF icon
1603
First Financial Corp
THFF
$931M
$508K ﹤0.01%
11,576
HELE icon
1604
Helen of Troy
HELE
$672M
$506K ﹤0.01%
8,184
BATRA icon
1605
Atlanta Braves Holdings Series A
BATRA
$3.58B
$502K ﹤0.01%
11,909
XPER icon
1606
Xperi
XPER
$367M
$501K ﹤0.01%
54,232
SHEN icon
1607
Shenandoah Telecom
SHEN
$646M
$501K ﹤0.01%
35,482
+4,800
+16% +$79.3K
PCT icon
1608
PureCycle Technologies
PCT
$1.19B
$500K ﹤0.01%
52,600
ARDX icon
1609
Ardelyx
ARDX
$1.26B
$494K ﹤0.01%
71,750
PRA
1610
DELISTED
ProAssurance
PRA
$493K ﹤0.01%
32,777
TBPH icon
1611
Theravance Biopharma
TBPH
$876M
$491K ﹤0.01%
60,907
HE icon
1612
Hawaiian Electric Industries
HE
$2.29B
$485K ﹤0.01%
50,148
+9,700
+24% +$120K
FLNA
1613
Filana Therapeutics
FLNA
$44.4M
$483K ﹤0.01%
16,396
DIN icon
1614
Dine Brands
DIN
$454M
$482K ﹤0.01%
15,448
ACMR icon
1615
ACM Research
ACMR
$5.14B
$481K ﹤0.01%
23,714
ACHR icon
1616
Archer Aviation
ACHR
$3.67B
$481K ﹤0.01%
158,792
EYE icon
1617
National Vision
EYE
$1.68B
$481K ﹤0.01%
44,045
PLRX icon
1618
Pliant Therapeutics
PLRX
$66.3M
$479K ﹤0.01%
42,768
+7,400
+21% +$92.6K
CVGW
1619
DELISTED
Calavo Growers
CVGW
$479K ﹤0.01%
16,804
VIR icon
1620
Vir Biotechnology
VIR
$1.5B
$478K ﹤0.01%
63,874
+13,600
+27% +$118K
GPRE icon
1621
Green Plains
GPRE
$1.16B
$477K ﹤0.01%
35,214
HSTM icon
1622
HealthStream
HSTM
$825M
$475K ﹤0.01%
16,479
MATW icon
1623
Matthews International
MATW
$888M
$474K ﹤0.01%
20,449
HAIN icon
1624
Hain Celestial
HAIN
$46.4M
$471K ﹤0.01%
54,558
HTLD icon
1625
Heartland Express
HTLD
$1.05B
$470K ﹤0.01%
38,245

Similar funds

Ensign Peak Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Ensign Peak Advisors held 1,730 positions worth $56.9B, up 3.9% from $54.7B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 2.4%. Ensign Peak Advisors opened 18 new positions and exited 24, leaving the 1,730-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q3 2024 buy was Invesco QQQ Trust: 68,400 shares worth $33.4M.
  • Ensign Peak Advisors added most to Oracle in Q3 2024, an estimated $98.8M increase.
  • Ensign Peak Advisors's biggest Q3 2024 reduction was Microsoft, cutting an estimated $122M.
  • Ensign Peak Advisors fully exited Coupang in Q3 2024, selling an estimated $16.3M.
  • Ensign Peak Advisors's ten largest holdings make up 32% of its $56.9B portfolio in Q3 2024.
  • Ensign Peak Advisors opened 18 new positions and closed 24 in Q3 2024.
  • Ensign Peak Advisors's portfolio value rose 3.9% quarter-over-quarter to $56.9B.

Based on Ensign Peak Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.